NASDAQ:TIL | Free Cash Flow | Instil Bio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.34M
2025-12-31-$7.08M
2025-03-31-$4.2M
2024-12-31-$10.56M$0.00-$10.56M
2024-03-31-$14.39M$0.00-$14.39M
2023-12-31-$13.38M$58,000.00-$13.44M
2023-03-31-$34.66M$8.47M-$43.13M
2022-12-31-$36.98M$13.01M-$49.99M
2022-03-31-$55.05M$20.24M-$75.29M
2021-12-31-$42.79M$18.46M-$61.25M
2021-03-31-$17.73M$9.13M-$26.86M
2020-12-31-$16.82M$45.27M-$62.09M
2020-03-31-$2.28M$968,000.00-$3.25M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$36.62M
2024-12-31-$55.7M$0.00-$55.7M
2023-12-31-$82.03M$20.66M-$102.69M
2022-12-31-$180.16M$84.59M-$264.75M
2021-12-31-$122.14M$57.83M-$179.97M
2020-12-31-$29.62M$50.82M-$80.43M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.